Literature DB >> 9759815

Treatment of infection with débridement and retention of the components following hip arthroplasty.

J R Crockarell1, A D Hanssen, D R Osmon, B F Morrey.   

Abstract

Forty-two patients (forty-two hips) who had an infection following a hip arthroplasty were managed with open débridement, retention of the prosthetic components, and antibiotic therapy. After a mean duration of follow-up of 6.3 years (range, 0.14 to twenty-two years), only six patients (14 per cent) -- four of nineteen who had had an early postoperative infection and two of four who had had an acute hematogenous infection -- had been managed successfully. Of the remaining thirty-six patients, three (7 per cent of the entire group) were being managed with chronic suppression with oral administration of antibiotics and thirty-three (79 per cent of the entire group) had had a failure of treatment. All nineteen patients who had a late chronic infection were deemed to have had a failure of treatment. Débridement had been performed at a mean of six days (range, two to fourteen days) after the onset of symptoms in the patients who had been managed successfully and at a mean of twenty-three days (range, three to ninety-three days) in those for whom treatment had failed. Débridement with retention of the prosthesis is a potentially successful treatment for early postoperative infection or acute hematogenous infection, provided that it is performed in the first two weeks after the onset of symptoms and that the prosthesis previously had been functioning well. In our experience, this procedure has not been successful when it has been performed more than two weeks after the onset of symptoms. Retention of the prosthesis should not be attempted in patients who have a chronic infection at the site of a hip arthroplasty as this approach universally fails.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759815     DOI: 10.2106/00004623-199809000-00009

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  69 in total

1.  Prosthetic Joint Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Treatment Options for Orthopedic Device-related Infections.

Authors:  Edna Toubes; John Segreti
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

3.  [Hip joint infections - Results of a questionnaire among 28 university orthopedic departments].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2011-09       Impact factor: 1.087

4.  Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention.

Authors:  O C El Helou; E F Berbari; B D Lahr; J E Eckel-Passow; R R Razonable; I G Sia; A Virk; R C Walker; J M Steckelberg; W R Wilson; A D Hanssen; D R Osmon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-27       Impact factor: 3.267

Review 5.  [Treatment of infected total knee arthroplasty. When does implant salvage make sense?].

Authors:  T Kern; H Gollwitzer; M Militz; V Bühren
Journal:  Orthopade       Date:  2006-09       Impact factor: 1.087

Review 6.  [Literature and own strategies concerning soft-tissue reconstruction and exposed osteosynthetic hardware].

Authors:  S Baumeister; L S Levin; D Erdmann
Journal:  Chirurg       Date:  2006-07       Impact factor: 0.955

7.  [The treatment of periprosthetic infections].

Authors:  C H Lohmann; M Fürst; O Niggemeyer; W Rüther
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

Review 8.  Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Prosthetic joint infections.

Authors:  Saima Aslam; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

10.  [Early-onset infection after hemiarthroplasty of the hip: an algorithm for surgical therapy].

Authors:  M Wick; I Maul; G Muhr
Journal:  Orthopade       Date:  2009-07       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.